Home › Islet Cell Adenoma › Minnesota › Rochester
Islet Cell Adenoma clinical trials in Rochester, MN
5 studies for Islet Cell Adenoma are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RecruitingPhase 2/3
- Mayo Clinic, Rochester
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecruitingPhase 3
- Investigative Site, Rochester
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Rochester
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RecruitingObservational study
- Mayo Clinic in Rochester, Rochester
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
Islet Cell Adenoma trials in other cities
- Los Angeles, CA5 studies
- St. Louis, MO5 studies
- Phoenix, AZ4 studies
- Washington, DC4 studies
- Salt Lake City, UT4 studies
- Portland, OR4 studies
- Columbus, OH4 studies
- Lexington, KY4 studies
- Chicago, IL4 studies
- Jacksonville, FL3 studies
- Irvine, CA3 studies
- Philadelphia, PA3 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Multiple Myeloma24 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Pancreatic Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.